Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 180 articles:
HTML format
Text format



Single Articles


    December 2017
  1. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Text format     Abstract available


  2. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed     Text format    


  3. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Text format     Abstract available


    November 2017
  4. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  5. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  6. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed     Text format    


  7. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Text format     Abstract available


    October 2017
  8. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Text format     Abstract available


  9. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  10. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Text format     Abstract available


  11. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed     Text format    


  12. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Text format     Abstract available


  13. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed     Text format    


    September 2017
  14. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Text format     Abstract available


  15. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed     Text format    


  16. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Text format     Abstract available


  17. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed     Text format    


  18. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Text format     Abstract available


  19. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Text format     Abstract available


  20. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Text format     Abstract available


  21. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Text format     Abstract available


  22. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed     Text format    


  23. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Text format     Abstract available


  24. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Text format     Abstract available


    August 2017
  25. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Text format     Abstract available


  26. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Text format     Abstract available


  27. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed     Text format    


  28. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Text format     Abstract available


  29. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed     Text format    


  30. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Text format     Abstract available


    July 2017
  31. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed     Text format    


  32. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Text format     Abstract available


  33. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed     Text format    


  34. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  35. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


  36. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Text format     Abstract available



  37. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed     Text format    


    June 2017
  38. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Text format     Abstract available


  39. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Text format     Abstract available


    May 2017
  40. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Text format     Abstract available


  41. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Text format     Abstract available


    April 2017
  42. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Text format     Abstract available


  43. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed     Text format    


    March 2017
  44. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Text format     Abstract available


  45. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed     Text format    


  46. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Text format     Abstract available


  47. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Text format     Abstract available


  48. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed     Text format    


  49. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


    February 2017
  50. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  51. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  52. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed     Text format    


  53. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed     Text format    


  54. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Text format     Abstract available


  55. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Text format     Abstract available


  56. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Text format     Abstract available


  57. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed     Text format    


  58. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Text format     Abstract available


    January 2017
  59. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Text format     Abstract available


  60. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Text format     Abstract available


  61. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  62. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Text format     Abstract available


    December 2016
  63. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Text format     Abstract available


  64. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed     Text format    


  65. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Text format     Abstract available


    November 2016
  66. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Text format     Abstract available


  67. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed     Text format    


  68. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed     Text format    


  69. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Text format     Abstract available


  70. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  71. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


  72. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Text format     Abstract available


    September 2016
  73. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed     Text format    


  74. MORGANTE F, Fasano A, Ginevrino M, Petrucci S, et al
    Impulsive-compulsive behaviors in parkin-associated Parkinson disease.
    Neurology. 2016 Sep 2. pii: 10.1212/WNL.0000000000003177.
    PubMed     Text format     Abstract available


  75. BJORNESTAD A, Tysnes OB, Larsen JP, Alves G, et al
    Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study.
    Neurology. 2016 Sep 2. pii: 10.1212/WNL.0000000000003213.
    PubMed     Text format     Abstract available


    August 2016
  76. QUATTRONE A, Morelli M, Williams DR, Vescio B, et al
    MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.
    Neurology. 2016 Aug 24. pii: 10.1212/WNL.0000000000003125.
    PubMed     Text format     Abstract available


  77. BARICHELLA M, Pacchetti C, Bolliri C, Cassani E, et al
    Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.
    Neurology. 2016 Aug 19. pii: 10.1212/WNL.0000000000003127.
    PubMed     Text format     Abstract available


  78. SIDIROPOULOS C, LeWitt PA, Odekerken VJ, Schuurman PR, et al
    GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
    Neurology. 2016;87:745-6.
    PubMed     Text format    


  79. BUCHMAN AS, Leurgans SE, Yu L, Wilson RS, et al
    Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2016 Aug 3. pii: 10.1212/WNL.0000000000003059.
    PubMed     Text format     Abstract available


    July 2016
  80. BOYD JT, Wangensteen KJ, Krawitt EL, Hamill RW, et al
    Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.
    Neurology. 2016;87:342.
    PubMed     Text format    


  81. BURCIU RG, Chung JW, Shukla P, Ofori E, et al
    Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002985.
    PubMed     Text format     Abstract available



  82. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
    Neurology. 2016;87:239.
    PubMed     Text format    


  83. JELLINGER KA, Logroscino G, Rizzo G, Copetti M, et al
    Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2016;87:237-8.
    PubMed     Text format    


  84. GIBBONS CH, Garcia J, Wang N, Shih LC, et al
    The diagnostic discrimination of cutaneous alpha-synuclein deposition in Parkinson disease.
    Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002919.
    PubMed     Text format     Abstract available


    June 2016
  85. GOODARZI Z, Mrklas KJ, Roberts DJ, Jette N, et al
    Detecting depression in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002898.
    PubMed     Text format     Abstract available


  86. COLLOBY SJ, McKeith IG, Burn DJ, Wyper DJ, et al
    Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Neurology. 2016 Jun 15. pii: 10.1212/WNL.0000000000002839.
    PubMed     Text format     Abstract available


    May 2016
  87. OSAKI Y, Fujita K, Abe T, Harada M, et al
    Mystery Case: Parkinsonism in a diabetic uremic patient.
    Neurology. 2016;86:e225-7.
    PubMed     Text format    


  88. VAN DER HEEDEN JF, Marinus J, Martinez-Martin P, Rodriguez-Blazquez C, et al
    Postural instability and gait are associated with severity and prognosis of Parkinson disease.
    Neurology. 2016 May 13. pii: 10.1212/WNL.0000000000002768.
    PubMed     Text format     Abstract available


  89. FACTOR SA, Bennett A, Hohler AD, Wang D, et al
    Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.
    Neurology. 2016 May 11. pii: 10.1212/WNL.0000000000002670.
    PubMed     Text format    


  90. CHAUDHURI KR
    Progression and biomarkers for Parkinson disease: Merging motor with nonmotor symptoms.
    Neurology. 2016 May 6. pii: 10.1212/WNL.0000000000002664.
    PubMed     Text format    


  91. MOLLENHAUER B, Zimmermann J, Sixel-Doring F, Focke NK, et al
    Monitoring of 30 marker candidates in early Parkinson disease as progression markers.
    Neurology. 2016 May 6. pii: 10.1212/WNL.0000000000002651.
    PubMed     Text format     Abstract available


  92. LATTANZI S, Silvestrini M, Verbeek MM, Mollenhauer B, et al
    Increased CSF biomarkers of angiogenesis in Parkinson disease.
    Neurology. 2016;86:1747-8.
    PubMed     Text format    


    April 2016
  93. BOHNEN NI, Muller ML, Sohn YH, Lee DH, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2016;86:1649-50.
    PubMed     Text format    


  94. MASSANO J, Bronstein JM
    Writeclick: Neuropsychological outcome after deep brain stimulation for Parkinson disease.
    Neurology. 2016;86:1563-4.
    PubMed     Text format    


  95. LOVERA LC, Rodriguez-Porcel F, Urrea-Mendoza E, Fasano A, et al
    Flamenco dancer posture: Unique "off" complication in Parkinson disease.
    Neurology. 2016;86:1462-3.
    PubMed     Text format    


  96. LEWITT PA, Fahn S
    Levodopa therapy for Parkinson disease: A look backward and forward.
    Neurology. 2016;86.
    PubMed     Text format     Abstract available


  97. SILVER DE, Trosch RM
    Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease.
    Neurology. 2016;86.
    PubMed     Text format     Abstract available


  98. DHALL R, Kreitzman DL
    Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety.
    Neurology. 2016;86.
    PubMed     Text format     Abstract available


  99. GUPTA S
    Advances in levodopa therapy for Parkinson disease.
    Neurology. 2016;86.
    PubMed     Text format    


    March 2016
  100. ABE K, Bohnen NI, Muller ML, van der Holst HM, et al
    Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.
    Neurology. 2016;86:1268-9.
    PubMed     Text format    


  101. BOHNEN NI, Muller ML
    Cerebral small vessel disease and incident parkinsonism: the RUN DMC study.
    Neurology. 2016;86:1268-9.
    PubMed     Text format    


  102. ABE K
    Cerebral small vessel disease and incident parkinsonism: the RUN DMC study.
    Neurology. 2016;86:1268-9.
    PubMed     Text format    



  103. Hepcidin ameliorates mitochondrial damage in a rat model of Parkinson's disease (P3.019).
    Neurology. 2016;86:1077.
    PubMed     Text format    


  104. SCHERFLER C, Gobel G, Muller C, Nocker M, et al
    Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism.
    Neurology. 2016 Mar 2. pii: 10.1212/WNL.0000000000002518.
    PubMed     Text format     Abstract available


    February 2016
  105. ROUSSAKIS AA, Politis M, Towey D, Piccini P, et al
    Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.
    Neurology. 2016 Feb 26. pii: 10.1212/WNL.0000000000002494.
    PubMed     Text format     Abstract available


  106. VELSEBOER DC, de Bie RM, Wieske L, Evans JR, et al
    Development and external validation of a prognostic model in newly diagnosed Parkinson disease.
    Neurology. 2016 Feb 17. pii: 10.1212/WNL.0000000000002437.
    PubMed     Text format     Abstract available


  107. CHIO A, Defazio G
    A new scale for prognostication in Parkinson disease: Of animals and men.
    Neurology. 2016 Feb 17. pii: 10.1212/WNL.0000000000002435.
    PubMed     Text format    


  108. STERLING NW, Wang M, Zhang L, Lee EY, et al
    Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds".
    Neurology. 2016 Feb 17. pii: 10.1212/WNL.0000000000002492.
    PubMed     Text format     Abstract available


  109. GRUNEWALD A, Klein C
    Urinary LRRK2 phosphorylation: Penetrating the thicket of Parkinson disease?
    Neurology. 2016 Feb 10. pii: 10.1212/WNL.0000000000002438.
    PubMed     Text format    


  110. PAGANO G, Ferrara N, Brooks DJ, Pavese N, et al
    Age at onset and Parkinson disease phenotype.
    Neurology. 2016 Feb 10. pii: 10.1212/WNL.0000000000002461.
    PubMed     Text format     Abstract available


  111. KEMPSTER PA
    Biomarkers for the progression of Parkinson disease.
    Neurology. 2016 Feb 10. pii: 10.1212/WNL.0000000000002473.
    PubMed     Text format    


  112. FRASER KB, Moehle MS, Alcalay RN, West AB, et al
    Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers.
    Neurology. 2016 Feb 10. pii: 10.1212/WNL.0000000000002436.
    PubMed     Text format     Abstract available


  113. ABBOTT RD, Ross GW, Petrovitch H, Masaki KH, et al
    Midlife milk consumption and substantia nigra neuron density at death.
    Neurology. 2016;86:512-9.
    PubMed     Text format     Abstract available


  114. CHEN H, Marder K
    Milk consumption and the risk of nigral degeneration.
    Neurology. 2016;86:496-7.
    PubMed     Text format    


    January 2016
  115. ODEKERKEN VJ, Boel JA, Schmand BA, de Haan RJ, et al
    GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
    Neurology. 2016 Jan 27. pii: 10.1212/WNL.0000000000002401.
    PubMed     Text format     Abstract available


  116. STOESSL AJ
    Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
    Neurology. 2016;86:228.
    PubMed     Text format    


  117. GAO X, O'Reilly EJ, Schwarzschild MA, Ascherio A, et al
    Prospective study of plasma urate and risk of Parkinson disease in men and women.
    Neurology. 2016 Jan 13. pii: 10.1212/WNL.0000000000002351.
    PubMed     Text format     Abstract available


  118. RIZZO G, Copetti M, Arcuti S, Martino D, et al
    Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2016 Jan 13. pii: 10.1212/WNL.0000000000002350.
    PubMed     Text format     Abstract available


  119. KOSCHMIDDER E, Weissbach A, Bruggemann N, Kasten M, et al
    A nonsense mutation in CHCHD2 in a patient with Parkinson disease.
    Neurology. 2016 Jan 13. pii: 10.1212/WNL.0000000000002361.
    PubMed     Text format    


    December 2015
  120. PAYER DE, Guttman M, Kish SJ, Tong J, et al
    D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002285.
    PubMed     Text format     Abstract available


  121. LOHLE M, Mende J, Wolz M, Beuthien-Baumann B, et al
    Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002286.
    PubMed     Text format     Abstract available


  122. TSAI HH, Liou HH, Muo CH, Lee CZ, et al
    Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.
    Neurology. 2015 Dec 23. pii: 10.1212/WNL.0000000000002307.
    PubMed     Text format     Abstract available


  123. HATANO T, Kurita N, Kobayashi M, Hattori N, et al
    Teaching Video NeuroImages: Re-emergent jaw tremor in Parkinson disease.
    Neurology. 2015;85:e181.
    PubMed     Text format    


    November 2015
  124. LABBE C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, et al
    Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies.
    Neurology. 2015;85:1680-6.
    PubMed     Text format     Abstract available


  125. WITJAS T, Carron R, Krack P, Eusebio A, et al
    A prospective single-blind study of Gamma Knife thalamotomy for tremor.
    Neurology. 2015;85:1562-8.
    PubMed     Text format     Abstract available


  126. GOLDSTEIN DS, Holmes C, Sharabi Y, Wu T, et al
    Survival in synucleinopathies: A prospective cohort study.
    Neurology. 2015;85:1554-61.
    PubMed     Text format     Abstract available


    October 2015
  127. VENTURA MI, Edwards JD, Barnes DE
    More than just a movement disorder: Why cognitive training is needed in Parkinson disease.
    Neurology. 2015 Oct 30. pii: 10.1212/WNL.0000000000002158.
    PubMed     Text format    


  128. LEUNG IH, Walton CC, Hallock H, Lewis SJ, et al
    Cognitive training in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2015 Oct 30. pii: 10.1212/WNL.0000000000002145.
    PubMed     Text format     Abstract available


  129. JANELIDZE S, Lindqvist D, Francardo V, Hall S, et al
    Increased CSF biomarkers of angiogenesis in Parkinson disease.
    Neurology. 2015 Oct 28. pii: 10.1212/WNL.0000000000002151.
    PubMed     Text format     Abstract available


  130. MUNOZ DG, Woulfe JM
    Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.
    Neurology. 2015 Oct 28. pii: 10.1212/WNL.0000000000002160.
    PubMed     Text format    


  131. TINAZZI M, Fasano A, Geroin C, Morgante F, et al
    Pisa syndrome in Parkinson disease: An observational multicenter Italian study.
    Neurology. 2015 Oct 21. pii: 10.1212/WNL.0000000000002122.
    PubMed     Text format     Abstract available


  132. BRONSTEIN JM, Odekerken VJ, Boel JA, Schmand BA, et al
    Neuropsychological outcome after deep brain stimulation for Parkinson disease.
    Neurology. 2015;85:1433-4.
    PubMed     Text format    


  133. ODEKERKEN VJ, Boel JA, Schmand BA, de Bie RM, et al
    Author response.
    Neurology. 2015;85:1433-4.
    PubMed     Text format    


  134. UNGER MM, Sakakibara R
    Does REM sleep behavior disorder have the guts to be Parkinson disease?
    Neurology. 2015 Oct 16. pii: 10.1212/WNL.0000000000002130.
    PubMed     Text format    


  135. HASSAN A, Benarroch EE
    Heterogeneity of the midbrain dopamine system: Implications for Parkinson disease.
    Neurology. 2015 Oct 16. pii: 10.1212/WNL.0000000000002137.
    PubMed     Text format    


  136. IACONO D, Geraci-Erck M, Rabin ML, Adler CH, et al
    Parkinson disease and incidental Lewy body disease: Just a question of time?
    Neurology. 2015 Oct 14. pii: 10.1212/WNL.0000000000002102.
    PubMed     Text format     Abstract available


  137. VAN DER HOLST HM, van Uden IW, Tuladhar AM, de Laat KF, et al
    Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.
    Neurology. 2015 Oct 7. pii: 10.1212/WNL.0000000000002082.
    PubMed     Text format     Abstract available


  138. LUCA CC, Rundek T
    Parkinsonism, small vessel disease, and white matter disease: Is there a link?
    Neurology. 2015 Oct 7. pii: 10.1212/WNL.0000000000002091.
    PubMed     Text format    


    September 2015
  139. PARK JE
    Reflections: Neurology and the Humanities. Not too late.
    Neurology. 2015;85:e88.
    PubMed     Text format    


  140. PIGOTT K, Rick J, Xie SX, Hurtig H, et al
    Longitudinal study of normal cognition in Parkinson disease.
    Neurology. 2015 Sep 11. pii: 10.1212/WNL.0000000000002001.
    PubMed     Text format     Abstract available


  141. HERSHEY LA, Peavy GM
    Cognitive decline in Parkinson disease: How steep and crowded is the slope?
    Neurology. 2015 Sep 11. pii: 10.1212/WNL.0000000000002003.
    PubMed     Text format    


  142. WANG L, Aasly JO, Annesi G, Bardien S, et al
    Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000002016.
    PubMed     Text format     Abstract available


  143. ROSSI S, Ulivelli M
    The olfactory side of Parkinson disease: Relevance for clinical practice.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000002005.
    PubMed     Text format    


  144. LEE DH, Oh JS, Ham JH, Lee JJ, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001999.
    PubMed     Text format     Abstract available


  145. FILLA A
    CAG repeats in idiopathic Parkinson disease: To screen or not to screen.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000002024.
    PubMed     Text format    


  146. MORTIBOYS H, Furmston R, Bronstad G, Aasly J, et al
    UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo.
    Neurology. 2015;85:846-52.
    PubMed     Text format     Abstract available


  147. HUOT P, Hutchison WD
    Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia.
    Neurology. 2015;85:840-1.
    PubMed     Text format    


  148. RUFFMANN C, Parkkinen L, Woulfe JM, Gray MT, et al
    Colonic mucosal alpha-synuclein lacks specificity as a biomarker for Parkinson disease.
    Neurology. 2015;85:834-5.
    PubMed     Text format    


  149. VISANJI NP, Lang AE, Hazrai LN
    Author response.
    Neurology. 2015;85:834-5.
    PubMed     Text format    


  150. WOULFE JM, Gray MT, Munoz G
    Colonic mucosal alpha-synuclein lacks specificity as a biomarker for Parkinson disease.
    Neurology. 2015;85:834.
    PubMed     Text format    


    August 2015
  151. OOSTERVELD LP, Allen JC Jr, Ng EY, Seah SH, et al
    Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.
    Neurology. 2015 Aug 26. pii: 10.1212/WNL.0000000000001953.
    PubMed     Text format     Abstract available


  152. KELLEY JM, Espay AJ, Dwivedi A, Lang AE, et al
    Placebo effect of medication cost in Parkinson disease: A randomized double-blind study.
    Neurology. 2015;85:742-3.
    PubMed     Text format    


  153. KELLEY JM
    Placebo effect of medication cost in Parkinson disease: a randomized double-blind study.
    Neurology. 2015;85:742-3.
    PubMed     Text format    


  154. XIE T, Vigil J, MacCracken E, Warnke P, et al
    Author Response.
    Neurology. 2015;85:557.
    PubMed     Text format    


  155. SIDIROPOULOS C
    Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD.
    Neurology. 2015;85:557.
    PubMed     Text format    


  156. GREENAMYRE JT, Sanders LH, Gasser T
    Fruit flies, bile acids, and Parkinson disease: A mitochondrial connection?
    Neurology. 2015 Aug 7. pii: 10.1212/WNL.0000000000001912.
    PubMed     Text format    


  157. LEE JY, Seo S, Lee JS, Kim HJ, et al
    Putaminal serotonergic innervation: Monitoring dyskinesia risk in Parkinson disease.
    Neurology. 2015 Aug 7. pii: 10.1212/WNL.0000000000001909.
    PubMed     Text format     Abstract available


  158. NIRENBERG MJ
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2015;85:483.
    PubMed     Text format    


  159. WORTHINGTON JM, Ney J
    The end of life with PD can be well-lived: the neurologist's role.
    Neurology. 2015;85:394-5.
    PubMed     Text format    


  160. KOGA S, Aoki N, Uitti RJ, van Gerpen JA, et al
    When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.
    Neurology. 2015;85:404-12.
    PubMed     Text format     Abstract available


    July 2015
  161. NA YC, Chang WS, Jung HH, Kweon EJ, et al
    Unilateral magnetic resonance-guided focused ultrasound pallidotomy for Parkinson disease.
    Neurology. 2015 Jul 15. pii: 10.1212/WNL.0000000000001826.
    PubMed     Text format    


  162. KIM SJ, Udupa K, Ni Z, Moro E, et al
    Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease.
    Neurology. 2015 Jul 8. pii: 10.1212/WNL.0000000000001806.
    PubMed     Text format     Abstract available


  163. MARDER K, Wang Y, Alcalay RN, Mejia-Santana H, et al
    Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.
    Neurology. 2015;85:89-95.
    PubMed     Text format     Abstract available


  164. SAFARPOUR D, Thibault DP, DeSanto CL, Boyd CM, et al
    Nursing home and end-of-life care in Parkinson disease.
    Neurology. 2015 Jul 2. pii: 10.1212/WNL.0000000000001715.
    PubMed     Text format     Abstract available


  165. XIE T, Guan R, Staisch J, Towle VL, et al
    Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS.
    Neurology. 2015 Jul 2. pii: 10.1212/WNL.0000000000001809.
    PubMed     Text format    


    June 2015
  166. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Development of excessive daytime sleepiness in early Parkinson disease.
    Neurology. 2015 Jun 17. pii: 10.1212/WNL.0000000000001737.
    PubMed     Text format     Abstract available


  167. RACETTE BA, Willis AW
    Time to change the blind men and the elephant approach to Parkinson disease?
    Neurology. 2015 Jun 12. pii: 10.1212/WNL.0000000000001739.
    PubMed     Text format     Abstract available


  168. MULLER ML, Albin RL, Bohnen NI, Jennings D, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2015;84:2292.
    PubMed     Text format    


  169. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Author Response.
    Neurology. 2015;84:2292.
    PubMed     Text format    


    May 2015
  170. GUSTAFSSON H, Nordstrom A, Nordstrom P
    Depression and subsequent risk of Parkinson disease: A nationwide cohort study.
    Neurology. 2015 May 20. pii: 10.1212/WNL.0000000000001684.
    PubMed     Text format     Abstract available


  171. BRIDEL C, Garibotto V
    Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.
    Neurology. 2015;84:e159.
    PubMed     Text format    


  172. MCKEOWN MJ, Peavy GM
    Biomarkers in Parkinson disease: It's time to combine.
    Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001692.
    PubMed     Text format    


  173. CAMPBELL MC, Koller JM, Snyder AZ, Buddhala C, et al
    CSF proteins and resting-state functional connectivity in Parkinson disease.
    Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001681.
    PubMed     Text format     Abstract available


    March 2015
  174. WEINTRAUB D, Papay K, Xie SX
    Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology. 2015;84:1386-7.
    PubMed     Text format    


  175. LIANG JW, Shanker VL, Groves M
    Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology. 2015;84:1386-7.
    PubMed     Text format    


  176. MASSANO J, Troster AI
    About deep brain stimulation.
    Neurology. 2015;84:e100-1.
    PubMed     Text format    


  177. ANANG JB, Postuma R
    Author response.
    Neurology. 2015;84:1285-6.
    PubMed     Text format    


    February 2015
  178. MACKAY CE, Szewczyk-Krolikowski K, Ben-Shlomo Y, Hu M, et al
    Author response.
    Neurology. 2015;84:546.
    PubMed     Text format    


  179. MONTGOMERY EB JR
    Functional connectivity in the basal ganglia network differentiates PD patients from controls.
    Neurology. 2015;84:546.
    PubMed     Text format    


    January 2015
  180. FUHR P, Zimmermann R, Gschwandtner U
    Author response.
    Neurology. 2015;84:104-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: